CJC-1295 with DAC 5mg Research Peptide

THRYV CJC-1295 with DAC 5mg is a synthetic research peptide supplied for laboratory and pre-clinical research use only. This compound is a modified growth hormone–releasing hormone (GHRH) analog that incorporates a Drug Affinity Complex (DAC) to extend peptide stability in research settings.

In pre-clinical and laboratory models, CJC-1295 with DAC has been examined in relation to growth hormone signaling pathways, peptide half-life extension, and receptor interaction dynamics. The DAC component has been studied for its role in albumin binding, supporting sustained peptide presence in controlled research environments.

Each vial is COA verified and independently tested to confirm purity and identity, ensuring consistency and reproducibility for research applications.

This compound is provided in research-grade quality, packaged to maintain stability and integrity during storage and handling.

For laboratory research use only. Not for human or veterinary consumption.
This product is not FDA-approved and is supplied strictly for research purposes.